The use of direct sequencing as a typing strategy is well acknowledged. Direct sequencing identifies all sequence motifs including new polymorphisms in heterozygous sequences. The earlier protocols for human leukocyte antigen HLA-DQB1 Sequencing-Based Typing (SBT) frequently encounter preferential amplification of one of the alleles that can lead to unreliable sequences or even to allelic dropout. In our new approach, the quality of the exon 2 sequences, now including both alleles to the same extend, was achieved by amplifying the HLA-DQB1*05/06 group into two groups by changing the common 3' amplification primer. In combination with exon 3 this updated HLA-DQB1 protocol provides a reliable approach for heterozygous sequencing.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1399-0039.2006.760_5.x | DOI Listing |
HLA
April 2024
Histocompatibility and Immunogenetics Laboratory, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
HLA-DQB1*02:01:01:21Q differs from HLA-DQB1*02:01:01:01 by one nucleotide substitution in the splice site in the beginning of intron 3.
View Article and Find Full Text PDFHLA
November 2023
Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
HLA-DQB1*06:475 differs from HLA-DQB1*06:35 by one nucleotide in exon 2.
View Article and Find Full Text PDFJ Intern Med
May 2023
Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.
Background: Immunogenicity to tumour necrosis factor inhibitors is a significant clinical problem leading to treatment failure and adverse events. The study aimed to assess human leukocyte antigen (HLA) associations with anti-drug antibody (ADAb) formation to infliximab.
Methods: Immune-mediated inflammatory disease patients on infliximab therapy (n = 612) were included.
HLA
May 2023
Department of Pediatrics, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
HLA
March 2023
Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
HLA-DQB1*03:03:29 differs from HLA-DQB1*03:03:02:01 by one nucleotide in exon 2.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!